Biotron Limited Ord

(BITRF)

By |

Profile

Biotron Ltd is a biotechnology company. The company is engaged in the funding and management of intermediate and applied biotechnology research and development projects. Its lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of HIV-1 and hepatitis C virus infections. Geographically, it operates only in Australia.

Contact Information

Website: www.biotron.com.au
Main Phone: +61 298050488
Address: 56 Delhi Road
Address 2: Suite 3.3
State: NSW
City / Town: Sydney
Country: AUS
Postal Code: 2113

Issuer Information

Exchange: OTO
Employees: 4

Equities News

Profile

Biotron Ltd is a biotechnology company. The company is engaged in the funding and management of intermediate and applied biotechnology research and development projects. Its lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of HIV-1 and hepatitis C virus infections. Geographically, it operates only in Australia.

Contact Information

Website: www.biotron.com.au
Main Phone: +61 298050488
Address: 56 Delhi Road
Address 2: Suite 3.3
State: NSW
City / Town: Sydney
Country: AUS
Postal Code: 2113

Issuer Information

Exchange: OTO
Employees: 4

Equities News

$ 0.064 $ 0.0129 (25.24%)
Last Price 0.064 Change $ 0.0129 Change % 25.24 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open 0.06 High 0.064 Low 0.06 Prev Close 0.0511
Last Trade Volume 219,000 52 Wk Hi 0.13 52 Wk Low 0.04
Market Cap 44.9 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 701,932,713.00 EPS (TTM) N/A PE Ratio N/A Exchange OTCPK